Here, we describe a protocol for developing a chick chorioallantoic membrane (CAM) xenografting model for human ovarian tissue and demonstrate the effectiveness of the technique, the graft revascularization time frame, and the tissue viability across a 6 day grafting period.
Ovarian tissue cryopreservation and transplantation is an effective strategy for preserving fertility but has one major drawback, namely massive follicle loss occurring shortly after reimplantation due to abnormal follicle activation and death. Rodents are benchmark models for investigating follicle activation, but the cost, time, and ethical considerations are becoming increasingly prohibitive, thus driving the development of alternatives. The chick chorioallantoic membrane (CAM) model is particularly attractive, being inexpensive and maintaining natural immunodeficiency up to day 17 postfertilization, making it ideal to study short-term xenografting of human ovarian tissue. The CAM is also highly vascularized and has been widely used as a model to explore angiogenesis. This gives it a remarkable advantage over in vitro models and allows the investigation of mechanisms affecting the early post-grafting follicle loss process. The protocol outlined herein aims to describe the development of a CAM xenografting model for human ovarian tissue, with specific insights into the effectiveness of the technique, the graft revascularization time frame, and the tissue viability across a 6 day grafting period.
The demand for fertility preservation for oncological and benign indications, as well as social reasons, has dramatically increased over recent decades. However, various treatments used to cure malignant and non-malignant diseases are highly toxic to the gonads and can result in iatrogenic premature ovarian insufficiency, ultimately leading to infertility1. Established techniques for fertility preservation include embryo cryopreservation, immature or mature oocyte vitrification, and ovarian tissue cryopreservation2,3,4. Ovarian tissue freezing is the only available option for preserving fertility in prepubertal girls or women who require immediate cancer therapy. The restoration of endocrine function following ovarian tissue transplantation occurs in over 95% of subjects, with live birth rates ranging from 18% to 42%5,6,7,8,9.
Although the transplantation of frozen-thawed ovarian tissue has proven successful, there is still room for improvement. Indeed, as ovarian cortical fragments are transplanted without vascular anastomosis, they experience a period of hypoxia during which graft revascularization takes place10,11,12. The vast majority of studies investigating human ovarian tissue transplantation have used a xenografting model, in which ovarian tissue is transplanted to immunodeficient mice. The complete revascularization of the xenografts takes around 10 days, with both the host and graft vessels contributing to the formation of functional vessels12,13,14. Around 50%-90% of the follicle reserve is lost during this hypoxic window before the completion of graft revascularization10,15,16. It has been strongly suggested that this massive follicle loss occurs through both direct follicle death, as demonstrated by a decrease in the absolute follicle numbers left after grafting, and the activation of primordial follicle growth, as indicated by changes in follicle proportions towards increased rates of growing follicles17,18.
Interestingly, previous research works using various animal ovarian tissues grafted to chick chorioallantoic membrane (CAM), which has a constitution mimicking the typical grafting site of the peritoneum, have reported the inhibition of spontaneous follicle activation, with the primordial follicle reserve staying intact for up to 10 days19,20,21,22. Our team previously demonstrated that the grafting of frozen-thawed human ovarian tissue to CAM constituted a reliable approach for investigating human ovarian tissue transplantation in its first ischemic stages23 and recently showed that this grafting method was able to counteract follicle activation24.
The CAM model is especially appealing not only because eggs are much cheaper than mice but also because of the highly vascularized nature of CAM, allowing scrutiny of the association between follicle activation and ovarian graft revascularization. The avian system is, indeed, one of the most common and versatile ways of studying angiogenesis25. Chick embryo development (ED) takes 21 days until hatching, and the CAM is formed within the first 4-5 days through the fusion of the allantois and chorion26. Notably, the chick embryo is a naturally immunodeficient host until day 17 of ED, so xenografting experiments can be performed without any risk of graft rejection27,28. Moreover, the CAM model approach does not raise any ethical or legal concerns in terms of European law29, making it an attractive alternative to other animal models. With regard to breeding conditions, chick embryos only need an incubator set at 37 °C with a relative air humidity of 40%-60%. These limited experimentation requirements significantly reduce the research costs compared to use of immunodeficient mice.
The protocol presented herein aims to describe the development of a CAM xenografting model for human ovarian tissue and provide specific insights into the effectiveness of the technique, the time frame of graft revascularization, and the tissue viability over a 6 day grafting period. This protocol could be of great interest for investigating the mechanisms behind early post-grafting follicle loss and studying the impact of several agents (growth factors, hormones, etc.) on this phenomenon.
The most challenging part of the protocol described here is making the small hole required to aspirate the albumen in order to detach the CAM from the eggshell prior to creating a window. Applying too much pressure can result in overpenetration or may even crack and destroy the egg, causing irrevocable damage to the CAM and its vasculature. To keep mistakes to a minimum during initial attempts to separate the CAM, it is strongly advised to practice making small holes in the eggshell of non-fertilized, grocery-bought eggs…
The authors have nothing to disclose.
The authors thank Mira Hryniuk, BA, for reviewing the English language of the article.
Agani hypodermic needle, 19 G | Terumo Europe | AN*1950R1 | 19 G needle to aspirate albumen |
Terumo syringe, 5 mL concentric Luer lock | Terumo Europe | SS*05LE1 | 5-mL sterile syringe |
Caseviewer v2.2 | 3DHISTECH | Image analysis software | |
Diethyl ether | Merck Chemicals | 603-022-00-4 | Sterile ether to traumatize the CAM |
Eosin Y aqueous solution 0.5% | Merck | 1098441000 | Staining solution |
Formaldehyde 4% aqueous solution buffered (Formalin 10%) | VWR | 97139010 | Formaldehyde used for tissue fixation |
Fridge | Liebherr | 7081260 | Fridge at 4 °C used for paraffin-embedding |
Heating plate | Schott | SLK2 | Hot plate used to dry the slides |
Incubator | Thermo Forma Scientific 3111 | 10365156 | Oven used for slide incubation |
Leica CLS 150 XE microscope cold light source | Leica | CLS 150 XE | Focal cold light source to candle the eggs |
Lens cleaning tissue, grade 541 | VWR | 111-5003 | Tissue to soak in sterile ether to traumatize the CAM |
Mayer's hematoxylin | MERCK | 1092491000 | Staining solution |
Methanol | VWR | 20847307 | Methanol |
Microtome | ThermoScientific-MICROM | HM325-2 | Microtome |
Pannoramic P250 Flash III | 3DHISTECH | / | Slide scanner at 20x magnification |
Paraformaldehyde | Merck | 1,04,00,51,000 | Paraffin-embedding solution |
Paraplast Plus R | Sigma | P3683-1KG | Paraffin |
Petri dish, 60×15 mm, sterile | Greiner | 628161 | Sterile petri dish |
Pin holder | Fine Science Tools | 26016-12 | Pin holder |
Polyhatch | Brinsea | CP01F | Egg incubator with automatic rotator |
Scroll saw blade, 132 mm | Sencys | / | Saw blade to create a window in the eggshell |
Stainless steel insert pins | Fine Science Tools | 26007-02 | Straight pin to make a hole in the eggshell |
Steril-Helios | Angelantoni Industrie | ST-00275400000 | Laminar flow hood |
Superfrost Plus bords rodés 90° | VWR | 631-9483 | Glass slides |
Tissue-Tek VIP 6Al | Sakura | 60320417-0711 VID6E3-1 | Automatic embedding device |
Titanium forceps | Fine Science Tools | 11602-16 | Forceps for eggshell removal and ovarian tissue manipulation |
Toluene, pa | VWR | 28701364 | Paraffin-embedding solution |